We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Potential Drug Candidates for Difficult-To-Treat Pediatric Leukemia

News   Apr 15, 2021 | Original story from Sanford Burnham Prebys Medical Discovery Institute

 
Potential Drug Candidates for Difficult-To-Treat Pediatric Leukemia

Credit: National Cancer Institute

 
 
Advertisement
 

RELATED ARTICLES

New Epigenetic Mechanisms Involved in Multiple Myeloma Growth

News

A team of researchers has analyzed the function of the histone demethylase KDM5A in multiple myeloma, one of the three major hematological cancers, and clarified the mechanism by which it promotes myeloma cell proliferation.

READ MORE

New Technology Transports the Genes for Therapeutic Agents Directly Into Tumor Cells

News

A new technology from UZH researchers enables the body to produce therapeutic agents on demand at exactly the point where they are needed. The innovation could reduce the side effects of cancer therapy and help better deliver COVID-19 treatments to the lungs.

READ MORE

Improving the Quality and Safety of Heparin

News

A team has analyzed Heparin, the blood-thinning drug, using a new method to that can pinpoint contaminants more accurately and quickly, providing greater quality control and safety.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE